Management of Heart Failure and Coronary Artery Disease in Patients with Chronic Kidney Disease

Seminars in Dialysis

Volumn 16, Issue 2, 2003, Pages 165-172

  Murphy, Sean W ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN ANTAGONIST; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; DOBUTAMINE; FIBRIC ACID DERIVATIVE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; METOPROLOL; MINOXIDIL; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PRAZOSIN; THALLIUM; THIAZIDE DIURETIC AGENT;

ANEMIA; ANGIOCARDIOGRAPHY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIASTOLE; DRUG CONTRAINDICATION; DRUG TOXICITY; ECHOCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; MYOCARDIAL DISEASE; NON INVASIVE MEASUREMENT; RELIABILITY; REVIEW; RISK FACTOR; STRESS ECHOCARDIOGRAPHY; SYSTOLE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; UREMIA; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; HEART MUSCLE ISCHEMIA; KIDNEY DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHRONIC DISEASE; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY DISEASE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY DISEASES; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 0043074879     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2003.16033.x     Document Type: Review

References (83)

1. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214-2219, 1999
2. Foley RN, Parfrey PS, Samak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9(suppl 12):S16-S23, 1998
3. U.S. Renal Data System: USRDS 1998 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, August 1998
4. 1999 Report, Volume 1: Dialysis and Renal Transplantation, Canadian Organ Replacement Register. Ottawa, Ontario: Canadian Institute for Health Information, June 1999
5. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024-2031, 1995
6. Foley RN, Parfrey P, Hefferton D, Kent GM, Murray DC, Barre PE: Advance prediction of early death in patients starting maintenance dialysis. Am J Kidney Dis 23:836-845, 1994
7. Foley RN, Parfrey P, Hefferton D, Kent GM, Murray DC, Barre PE: Clinical and echocardiographic disease in end-stage renal disease: prevalence, associations, and risk factors. Kidney Int 47:186-192, 1995
8. Covic A, Goldsmith DJ, Georgescu G, Venning MC, Ackrill P: Echocardiographic findings in long-term long hour hemodialysis patients. Clin Nephrol 45:104-110, 1996
9. Churchill D, Taylor D, Cook R, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H: Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 19:214-234, 1992
10. Harnett JD, Foley RN, Kent GM, Purchase L, Kent G, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47:884-890, 1995
11. Foley RN, Parfrey P, Hefferton D, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
12. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 157:2413-2446, 1997
13. Canadian Hypertension Recommendations Working Group: The 2001 Canadian recommendations for the management of hypertension: Part one - assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. Can J Cardiol 18:604-624, 2002
14. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54:561-569, 1998
15. Lowrie EG, Lew NL: Commonly measured laboratory values in hemodialysis patients, relationships among them and to death risk. Semin Nephrol 12:276-283, 1992
16. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP: J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 136:438-448, 2002
17. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity and mortality in end stage renal disease. Am J Kidney Dis, 1996 28:53-61
18. Besarab A, Bolton WK, Brown JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoietin. N Engl J Med 339:584-590, 1998
19. Foley RN, Parfrey PS, Morgan J, Barre PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA: Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 58:1325-1335, 2000
20. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30(4 suppl 3):S192-S240, 1997
21. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61:2235-2239, 2002
22. Chan C, Floras JS, Miller JA, Pierratos A: Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 17:1518-1521, 2002
23. Cruikshank JM, Lewis J, Moore V, Dodd C: Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 6:85-90, 1992
24. Steering Committee and Membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure: Consensus recommendations for the management of chronic heart failure. Am J Cardiol 83:2A-38A, 1999
25. Hunt SA, Baker DW, Chin MH, Cinguegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report to the ACC/AHA task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure), available at http://www.acc.org, 2001
26. Hara Y, Hamada M, Shigematsu Y, Murakami B, Hiwada K: Beneficial effect of β-adrenergic blockade on left ventricular function in hemodialysis patients. Clin Sci 101:219225, 2001
27. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349-1355, 1996
28. CIBIS Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial of beta-blockade in heart failure. Lancet 353:9-13, 1999
29. MERIT-HF Study Group: Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001-2007, 1999
30. Young JB, Gheorghiade M, Uretsky BF, Patterson JH, Adams KF: Superiority of "triple" drug therapy in heart failure. Insights from the PROVED and RADIANCE trials. J Am Coll Cardiol 32:686-692, 1998
31. Roig E, Betriu A, Castaner A, Magrina J, Sanz G, Navarro-Lopez F: Disabling angina pectoris with normal coronary arteries in patients undergoing long term dialysis. Am J Med 71:431-434, 1991
32. Rostand SG, Kirk KA, Rutsky EA: Dialysis associated ischemic heart disease: Insights from coronary angiography. Kidney Int 25:653-659, 1984
33. Mosseri M, Schaper J, Admon D, Hasin Y, Gotsman MS, Sapoznikov D, Pickering JG, Yarom R: Coronary capillaries in patients with congestive cardiomyopathy or angina pectoris with patent main coronary arteries. Ultrastructural morphometry of endomyocardial biopsy samples. Circulation 84:203-210, 1991
34. Braun WE, Philips DF, Vidt DG, Novick AC, Nakamoto S, Popowniak KL, Paganini E, Magnusson M, Pohl M, Steinmuller DR, Protiva D, Buszta C: Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 16:603-607, 1984
35. Cohn PF: Detection and prognosis of asymptomatic patients with silent myocardial ischemia. Am J Cardiol 61(suppl 3):4B-6B, 1988
36. Kasiske BL, Ramos EL, Gaston RS, Bia MJ, Danovitch GM, Bowen PA, Lundin PA, Murphy KJ: The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 6:1-34, 1995
37. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NL: Guidelines for perioperative cardiovascular evaluation for non-cardiac surgery. Report of the ACC/AHA task force on practice guidelines (committee on perioperative cardiovascular evaluation for non-cardiac surgery). J Am Coll Cardiol 27:910-948, 1996
38. Palda VA, Detsky AS: Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major non-cardiac surgery. Ann Intern Med 127:309-312, 1997
39. Morrow CE, Schwartz JS, Sutherland DE, Simmons RL, Ferguson RM, Kjellstrand CM, Najarian JS: Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Med 146:331-335, 1983
40. Philipson JD, Carpenter BJ, Itzkoff J, Hakala TR, Rosenthal JT, Taylor RJ, Puschett JB: Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 81:630-634, 1986
41. Marwick TH, Lauer MS, Nally J, Braun W: Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med 244:155-161, 1998
42. Herzog CA, Marwhick TH, Pheley AM, White CW, Rao VK, Dick CD: Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 33:1080-1090, 1999
43. Bates JR, Sawada SG, Segar DS, Spaedy AJ, Petrovic O, Fineberg NS, Fiegenbaum H, Ryna T: Evaluation using dobutamine stress echocardiography in patients with insulin dependent diabetes mellitus before kidney and/or pancreas transplant. Am J Cardiol 77:175-179, 1996
44. Kasiske BL: Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32(suppl 3):S142-S156, 1998
45. Seliger SL, Weiss NS, Gillen DL, Kestenbaum B, Ball A, Sherrad DJ, Stehman-Breen CO: HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61:297-304, 2002
46. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA: Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159:1077-1080, 1999
47. Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Selhub J, Dworkin L, Rosenberg IH: Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol 17:2554-2558, 1997
48. Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Bagley P, Massy ZA, Jacques PF, Dworkin L, Selhub J: Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients. Kidney Int 17(suppl): S246-S252, 2001
49. Murphy SW, Foley RN, Parfrey PS: Screening and treatment for cardiovascular disease in patients with chronic renal disease. Am J Kidney Dis 32(5 suppl 3):S184-S199, 1998
50. Gibbons RJ, Chatterjee K, Daley J, et al.: ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 33:2092-2197, 1999
51. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE III, Weaver WD: ACC/AHA guidelines for the management of patients with acute myocardial infarction: 1999 update: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, available at http://www.acc.org, 1999
52. Kaufman JS, Fiore L, Hasbargen JA, O'Connor TZ, Perdriset G: A pharmacodynamic study of clopidogrel in chronic hemodialysis patients. J Thromb Thrombolysis 10:127-131, 2000
53. Clough RA, Leavitt BJ, Morton JR, Plume SK, Hernandez F, Nugent W, Lahey SJ, Ross CS, O'Connor GT: The effect of comorbid illness on mortality outcomes in cardiac surgery. Arch Surg 137:428-432, 2002
54. Goldsmith DJA, Covic A: Coronary artery disease in uremia: etiology, diagnosis, and therapy. Kidney Int 60:2059-2078, 2001
55. CASS principal investigators and their associates: Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery: survival data. Circulation 68:939-950, 1983
56. Szczech LA, Reddan DN, Owen WF, Califf R, Racz M, Jones RH, Hannan EL: Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int 60:292-299, 2001
57. Herzog CA, Ma JZ, Collins AJ: Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int 56:324-3332, 1999
58. Rinehart AI Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA: A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in patients with dialysis-dependent renal failure. Am J Kidney Dis 25:281-290, 1995
59. Dacey LJ, Liu JY, Braxton JH, Weintraub RM, DeSimone J, Charlesworth DC, Lahey SJ, Ross CS, Hernandez F Jr, Leavitt BJ, O'Connor GT: Long-term survival of dialysis patients after coronary bypass grafting. Ann Thorac Surg 74:458-462, 2002
60. Manske CL, Wang Y, Rector T, Wilson RF, White CW: Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 340:998-1002, 1992
61. Landau C, Lange RA, Hillis LD: Percutaneous transluminal coronary angioplasty. N Engl J Med 330:981-993, 1994
62. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB: The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39:1113-1119, 2002
63. Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H, Bazari H, Palacios IF: Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 102:2966-2972, 2000
64. Asinger RW, Henry TD, Herzog CA, Pauken PR, Kane RL: Clinical outcomes of PTCA in chronic renal failure: a case-control study for comorbid features and evaluation of dialysis dependence. J Invasive Cardiol 13:21-28, 2001
65. Rubenstein MH, Sheynberg BV, Harrell LC, Schunkert H, Bazari H, Palacios IF: Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol 87:856-860, 2001
66. Szczech LA, Best PJ, Crowley E, Brooks MM, Berger PB, Bittner V, Gersh BJ, Jones R, Califf RM, Ting HH, Whitlow PJ, Detre KM, Holmes D: Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 105:2253-2258, 2002
67. Le Feuvre C, Dambrin G, Helft G, Tabet S, Beygui F, Legendre C, Peraldi MN, Vacheron A, Metzger JP: Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am J Cardiol 85:1365-1368, 2000
68. Tabet S, Le Feuvre C, Dambrin G, Helft G, Beygui F, Vacheron A, Metzger JP: Coronary angioplasty in hemodialysis patients. Arch Mal Coeur Vaiss 93:807-812, 2000
69. Azar RR, Prpic R, Ho KK, Kiernan FJ, Shubrooks SJ Jr, Baim DS, Popma JJ, Kuntz RE, Cohen DJ: Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 86:485-489, 2000
70. Malanuk RM, Nielsen CD, Theis P, Assey ME, Usher BW, Leman RB: Treatment of coronary artery disease in hemodialysis patients: PTCA vs. stent. Catheter Cardiovasc Interv 54:459-463, 2001
71. Schmidt A, Stefenelli T, Schuster E, Mayer G: Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 37:56-63, 2001
72. Brown JH, Vites NP, Testa HJ, Prescott MC, Hunt LP, Gokal R, Mallick NP: Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant 8:433-437, 1993
73. Travain MI, Wexler JP: Pharmacological stress testing. Semin Nucl Med 29:298-318, 1999
74. Dahan M, Legallicier B, Himbert D, Faraggi M, Aubry N, Siohan P, Viron B, Gourgon R, Mignon F: Diagnostic value of myocardial thallium stress scintigraphy in the detection of coronary artery disease in patients undergoing chronic hemodialysis. Arch Mal Coeur Vaiss 88:1121-1123, 1995
75. Boudreau RJ, Strony JT, duCret RP, Kuni CC, Wang Y, Wilson RF, Schwartz JS, Castaneda-Zuniga WR: Perfusion thallium imaging for the study of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology 175:103-105, 1990
76. Marwick TH, Steinmuller DR, Underwood DA, Hobbs RE, Go RT, Swift C, Braun WE: Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 49:100-103, 1990
77. Vandenberg BF, Rossen JD, Grover-McKay M, Shammas NW, Burns TL, Rezad K: Evaluation of diabetic patients for renal and pancreas transplantation. Transplant 9:1230-1235, 1996
78. Dahan M, Viron BM, Fraggi M, Himbert DL, Lagallicier BJ, Kolta AM, Pessione F, Le Guludec D, Gourgon R, Mignon FE: Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 54:255-262, 1998
79. Koyanagi T, Nishida H, Kitamura M, Endo M, Koyanagi H, Kawaguchi M, Magosaki N, Sumiyoshi T, Hosoda S: Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg 61:1793-1796, 1996
80. Simsir SA, Kohlman-Trigoboff D, Flood R, Lindsay J, Smith BM: A comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients on hemodialysis. Cardiovasc Surg 6:500-505, 1998
81. Ohmoto Y, Ayabe M, Hara K, Sugimoto T, Tagawa H, Fukuda S, Suma H, Wanibuchi Y, Tamura T: Long-term outcome of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in patients with end-stage renal disease. Jpn Circ J 63:981-987, 1999
82. Agirbasli M, Weintraub WS, Chang GL, King SB, Guyton RA, Thompson TD, Alameddine F, Ghazzal ZM: Outcome of coronary revascularization in patients on renal dialysis. Am J Cardiol 86:395-399, 2000
83. Ivens K, Gradaus F, Heering P, Schoebel FC, Klein M, Schulte HD, Strauer BE, Grabensee B: Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. Int Urol Nephrol 32:717-723, 2001